Entera Bio (ENTX) EPS (Basic) Growth (3y) (2022 - 2026)
Entera Bio (ENTX) EPS (Basic) Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.05 Bn | 131.20 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.49 Bn | 60.31 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 56.79 Bn | 51.65 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.14 Bn | 37.05 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 27.71 Bn | 9.32 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | -38.31% |
| 10 | Entera Bio | 164.72 Mn | 153.41 Mn | - | -3.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.03% |
| Mar 31, 2026 | 0.18% |
| Dec 31, 2025 | 13.61% |
| Sep 30, 2025 | 11.86% |
| Jun 30, 2025 | 19.20% |
| Mar 31, 2025 | 22.83% |
| Dec 31, 2024 | 26.37% |
| Sep 30, 2024 | 10.53% |
| Jun 30, 2024 | 14.29% |
| Mar 31, 2024 | 18.81% |
| Jun 30, 2023 | 22.74% |
| Jun 30, 2022 | 13.83% |